Year archive

Genix Pharmaceuticals Corporation — 2020 filings

All 26 regulatory filings released by Genix Pharmaceuticals Corporation (GENX) in 2020, sourced directly from the official regulator.

26 Filings

2020 Period

2020 filings (26)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-09-29	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-09-29	English
Interim MD&A - English.pdf Interim / Quarterly Report	2020-09-29	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2020-09-29	English
Material change report - English.pdf Declaration of Voting Results & Voting Rights Announcements	2020-09-23	English
News release - English.pdf AGM Information	2020-09-22	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2020-08-25	English
Material change report - English.pdf Regulatory Filings	2020-08-25	English
Material change report - English.pdf Capital/Financing Update	2020-08-12	English
News release - English.pdf Capital/Financing Update	2020-08-06	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Capital/Financing Update	2020-08-05	English
News release - English.pdf Capital/Financing Update	2020-08-03	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-06-24	English
Interim MD&A - English.pdf Interim / Quarterly Report	2020-06-24	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2020-06-24	English
News release - English.pdf Capital/Financing Update	2020-06-22	English
News release - English.pdf M&A Activity	2020-03-27	English
News release - English.pdf Capital/Financing Update	2020-03-04	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2020-02-28	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2020-02-28	English
Annual MD&A - English.pdf Management Reports	2020-02-28	English
Audited annual financial statements – English.pdf Annual Report	2020-02-28	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2020-02-28	English
Material change report - English.pdf Regulatory Filings	2020-02-20	English
News release - English.pdf Capital/Financing Update	2020-02-14	English
News release - English.pdf Regulatory Filings	2020-01-14	English